SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biogen
BIIB 187.65+0.9%Jan 9 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Harold Engstrom who wrote (906)3/22/1999 5:39:00 PM
From: Joe Dancy   of 1686
 
Merrill has Biogen as both short and long term buy. I interviewed Jim McCamant of the Medical Technology Letter last week for Mark Johnson's IFC site on Silicon Investor and asked him what he thought of the company. McCamant was not real high on the company - which was surprising because Jim Oberweis liked the company and I had talked to him a few weeks earlier.

You can listen to his specific comments on Biogen by going to audioinvestor.com - if you don't want to listen to the entire interview go to minute 22 of the 25 minute tape to hear his take.

I'm not long or short here - but I usually rely on Merrill's research and it has done me well in this sector. He took his biggest shot at Amgen a few minutes earlier in the interview.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext